Hospira Supports Tsunami Disaster Relief With $300,000 and Medical Product Donations
30 Dezembro 2004 - 8:57PM
PR Newswire (US)
Hospira Supports Tsunami Disaster Relief With $300,000 and Medical
Product Donations LAKE FOREST, Ill., Dec. 30 /PRNewswire-FirstCall/
-- Hospira, Inc. and its employees today announced that they are
contributing $300,000, as well as product donations, to support the
relief efforts related to last weekend's earthquake and tsunamis
affecting southern Asia and the eastern coast of Africa. Hospira
also will match financial contributions from its employees to
support relief efforts, up to $50,000. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO ) "The Hospira
family expresses deep sympathy to all those affected by this
terrible tragedy," said Christopher B. Begley, chief executive
officer, Hospira. "Hospira is committed to our global community,
and we hope that our donations will help restore health and
wellness to this devastated region." Hospira contributed a $250,000
cash grant to the American Red Cross International Response Fund
and a $50,000 cash grant to AmeriCares, a leading non-profit aid
organization, to support their efforts for this tragedy. In
addition, Hospira donated over 29,000 pounds of medical products
via AmeriCares. Hospira's donation included a variety of
intravenous (I.V.) solutions and injectable drugs, as well as
sterile water. Hospira's products are being included in AmeriCares
airlifts to aid disaster survivors in Sri Lanka, India and
Indonesia. For more information about the American Red Cross or
AmeriCares, please visit their Web sites at
http://www.redcross.org/ and http://www.americares.org/,
respectively. About Hospira Hospira, Inc. is a global specialty
pharmaceutical and medication delivery company dedicated to
Advancing Wellness(TM) by developing, manufacturing and marketing
products that help improve the safety and efficacy of patient care.
Created from the core global hospital products business of Abbott
Laboratories, Hospira is a new company with 70 years of service to
the hospital industry. The company's portfolio includes one of the
industry's broadest lines of generic acute-care injectables, which
help address the high cost of proprietary pharmaceuticals in
hospitals; integrated solutions for medication management and
infusion therapy; and a full-service contract manufacturing
business. Headquartered in Lake Forest, Ill., north of Chicago,
Hospira has more than 14,000 employees and 15 manufacturing
facilities worldwide. Hospira's news releases and other information
can be found at http://www.hospira.com/ . Private Securities
Litigation Reform Act of 1995 -- A Caution Concerning
Forward-Looking Statements Some statements in this news release may
be forward-looking statements for purposes of the Private
Securities Litigation Reform Act of 1995. Hospira cautions that
these forward-looking statements are subject to risks and
uncertainties that may cause actual results to differ materially
from those indicated in the forward-looking statements. Economic,
competitive, governmental, technological and other factors that may
affect Hospira's operations and may cause actual results to be
materially different from expectations include the risks and
uncertainties set forth in the information statement under the
heading "Risk Factors" in the most recent version of the Form 10
filed with the Securities and Exchange Commission, which are
incorporated by reference. Hospira undertakes no obligation to
release publicly any revisions to forward-looking statements as the
result of subsequent events or developments.
http://www.newscom.com/cgi-bin/prnh/20040503/HSPLOGO
http://photoarchive.ap.org/ DATASOURCE: Hospira, Inc. CONTACT:
Media, Stacey Eisen, +1-224-212-2276, or Jason Hodges,
+1-224-212-2863, or Financial Community, Lynn McHugh,
+1-224-212-2363, both of Hospira, Inc. Web site:
http://www.hospira.com/
Copyright